Morton Sodium Chloride USP Recalled for Slightly High Bromide Levels
Morton Salt Co. is recalling specific lots of Sodium Chloride USP due to slightly out-of-specification bromide levels.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which is defined as unlikely to cause adverse health consequences. The source text describes the deviation as 'slightly out of specification' and does not report any illnesses or injuries.
Plain-English summary
Morton Salt Co. is recalling 531,950 lbs of Morton Sodium Chloride, USP, Granular. The product is packaged in kraft paper bags, fiber drums, and semi-bulk bags, and is shipped in 80 lb bags, 350 lb drums, and 2000 lb semi-bulk sacks. The affected lots are OCT251BC01, NOV041BA01, and NOV071BA01.
The recall was initiated because the product was found to contain a slightly out-of-specification level of bromides, exceeding the limit for USP Sodium Chloride. The FDA has classified this as a Class III recall.
The product was distributed nationwide, as well as to Puerto Rico and Ireland. Consumers and healthcare facilities should check their inventory for these specific lot numbers and stop using the product if found.
The recalled product
- Product
- Morton, Sodium Chloride, USP, Granular, packaged in kraft paper bags, fiber drums, and semi-bulk bags. Product is shipped in 80 lb bags, 350 lb drums & 2000 lb semi-bulk sacks. Manufactured by Morton Salt, Inc., Chicago, Illinois 60606-1743.
- Manufacturer
- Morton Salt Co.
- Category
- Drug — Pharmaceutical Excipient
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: OCT251BC01
- NOV041BA01 & NOV071BA01.
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · impurity
See all →- ModerateAjanta Pharma Recalls Fluphenazine Hydrochloride Tablets Due to Impurity Failure
FDA (Drugs) · 2026-09-16
- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
Similar recalls
- SevereBaxter Recalls Sodium Chloride Injection Bags Due to Plastic Fragments
FDA (Drugs) · 2015-04-15
- ModerateMorton Salt Canisters Recalled for Mislabeling Iodized Salt as Plain Salt
FDA (Food) · 2020-02-19
- CriticalBaxter Recalls Sodium Chloride Injection Bags Due to Particulate Matter
FDA (Drugs) · 2014-09-24
- LowPQ Corporation Recalls Epsom Salt Bags Due to High Iron Levels
FDA (Drugs) · 2016-01-13
- LowMorton Natural Sea Salt Recalled for Iodized Salt Packaging Error
FDA (Food) · 2018-09-05
- CriticalSodium chloride injection containers recalled over presence of particulate matter
FDA (Drugs) · 2025-09-10